Skip to main content

Stempoint Capital Lp

Source: SEC Form 13F · as of Mar 2026

Stempoint Capital Lp holds 48 biotech & pharma companies tracked by BioSniper, totaling $678.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

48

Total value held

$678.4M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Scholar Rock Holding Corp (SRRK)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
SRRKScholar Rock Holding Corp2,070,992$101.8M
ABVXAbivax SA627,582$69.9M
RVMDREVOLUTION MEDICINES, INC.563,264$54.8M
IMVTImmunovant, Inc.1,492,988$37.1M
ELVNEnliven Therapeutics, Inc.726,876$28.5M
BHVNBiohaven Ltd.3,188,982$27.0M
ROIVRoivant Sciences Ltd.771,600$21.4M
ARQTArcutis Biotherapeutics, Inc.827,584$19.5M
GPCRStructure Therapeutics Inc.400,534$19.3M
SRZNSurrozen Inc.721,620$19.2M
CYTKCYTOKINETICS INC259,154$17.1M
SYRESpyre Therapeutics, Inc.335,212$16.9M
DNLIDenali Therapeutics Inc.853,122$16.4M
CLDXCelldex Therapeutics, Inc.508,534$16.1M
PTGXProtagonist Therapeutics, Inc145,154$15.3M
DNTHDianthus Therapeutics, Inc. /DE/171,004$14.4M
DFTXDefinium Therapeutics Inc.650,966$12.3M
BIOABioAge Labs, Inc.677,308$11.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.361,316$11.6M
ACADACADIA PHARMACEUTICALS INC485,132$10.8M
ASMBASSEMBLY BIOSCIENCES, INC.370,870$10.3M
ALMSALUMIS INC.459,132$10.1M
NRIXNurix Therapeutics, Inc.630,452$9.8M
ZURAZura Bio Ltd1,507,040$9.0M
TNGXTango Therapeutics, Inc.401,838$8.4M
RLMDRELMADA THERAPEUTICS, INC.1,194,818$8.3M
XFORX4 Pharmaceuticals, Inc1,701,484$7.0M
PCVXVaxcyte, Inc.118,122$6.9M
WHWKWhitehawk Therapeutics, Inc.1,878,738$6.5M
TENXTENAX THERAPEUTICS, INC.377,400$6.0M
PHVSPharvaris N.V.173,274$4.9M
IVVDInvivyd, Inc.3,749,092$4.9M
JBIOJade Biosciences, Inc.308,068$4.3M
MPLTMapLight Therapeutics, Inc.200,000$4.1M
AVTXAvalo Therapeutics, Inc.269,484$4.0M
IONSIONIS PHARMACEUTICALS INC52,770$4.0M
IMCRImmunocore Holdings plc127,086$3.8M
FBRXForte Biosciences, Inc.116,040$3.0M
SIONSionna Therapeutics, Inc.73,080$2.9M
SABSSAB BIOTHERAPEUTICS, INC.750,000$2.9M
SLDBSolid Biosciences Inc.390,806$2.8M
LPCNLipocine Inc.320,840$2.6M
QUREuniQure N.V.156,132$2.6M
LBRXLB PHARMACEUTICALS INC100,000$2.5M
CCCCC4 Therapeutics, Inc.906,472$2.4M
CAPRCAPRICOR THERAPEUTICS, INC.75,184$2.3M
STROSUTRO BIOPHARMA, INC.46,590$1.2M
VTGNVistagen Therapeutics, Inc.1,233,498$116K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.